An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants (2025)
- Authors:
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; OLIVEIRA, SERGIO COSTA - ICB ; SILVA, FÁBIO MAMBELLI - ICB ; ARAUJO, ANA CAROLINA VALENTE SANTOS CRUZ DE - ICB ; FARIAS, JÉSSICA PIRES - ICB ; ANDRADE, KÍVIA QUEIROZ DE - ICB
- Unidade: ICB
- DOI: 10.3390/pathogens14010023
- Subjects: MICROBIOLOGIA; IMUNOLOGIA; VACINAS VIRAIS; COVID-19; PANDEMIAS; VARIAÇÃO GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SILVA, Fábio Mambelli et al. An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants. Pathogens, v. 14, n. 1, p. 19 , 2025Tradução . . Disponível em: https://doi.org/10.3390/pathogens14010023. Acesso em: 15 abr. 2026. -
APA
Silva, F. M., Araujo, A. C. V. S. C. de, Farias, J. P., Andrade, K. Q. de, Minóprio, P. M. C., Leite, L. C. de C., et al. (2025). An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants. Pathogens, 14( 1), 19 . doi:10.3390/pathogens14010023 -
NLM
Silva FM, Araujo ACVSC de, Farias JP, Andrade KQ de, Minóprio PMC, Leite LC de C, Ferreira LC de S, Oliveira SC. An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants [Internet]. Pathogens. 2025 ; 14( 1): 19 .[citado 2026 abr. 15 ] Available from: https://doi.org/10.3390/pathogens14010023 -
Vancouver
Silva FM, Araujo ACVSC de, Farias JP, Andrade KQ de, Minóprio PMC, Leite LC de C, Ferreira LC de S, Oliveira SC. An update on anti-COVID-19 vaccines and the challenges to protect against new SARS-CoV-2 variants [Internet]. Pathogens. 2025 ; 14( 1): 19 .[citado 2026 abr. 15 ] Available from: https://doi.org/10.3390/pathogens14010023 - Findings and outcomes of hospitalized unvaccinated patients during the COVID-19 pandemic: impact of comorbidities on clinical, laboratory, and immunological parameters
- Declining COVID-19 vaccination coverage in Brazil: a global health warning
- Pathogenicity and virulence of Brucella: strategies for metabolic adaptation and immune evasion
- The impact of STING signaling on myeloid cells highlights macrophages as the major player in controlling Brucella abortus
- Correction: Inulin diet uncovers complex diet-microbiota-immune cell interactions remodeling the gut epithelium
- Bacillus Calmette-Guérin-Trained macrophages elicit a protective inflammatory response against the pathogenic bacteria Brucella abortus
- Brucella abortus induces dynamin-related protein 1 (DRP1)-dependent mitochondrial fission in infected macrophages via stress sensor IRE1α altering metabolic function
- Persistent articular infection and host reactive response contribute to Brucella-induced spondyloarthritis in SKG mice
- Broad innate immune activation enhances the protective efficacy of rBCG-LTAK63 against Mycobacterium tuberculosis
- Long-term trotective immune responses induced by rBCG-RBD/rRBD heterologous prime/boost immunization strategy: fusion of RBD-Wuhan with LTB adjuvant induces cross-reactivity with SARS-CoV-2 variant Omicron
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
